Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Journal of Gastrointestinal Cancer|March 2, 2011
Expression profile as predictor of relapse after adjuvant treatment in gastric cancerMaría Sereno, Javier De Castro, Paloma Cejas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)Pilar Garrido, Javier de Castro, Ángel Concha, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 3, 2009
Early and prolonged intake of partially hydrogenated fat alters the expression of genes in rat adipose tissueDaniella E Duque-Guimarães, Javier de Castro, Javier Martinez-Botas, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Fernando López-Ríos, Luis Paz-Ares, Julián Sanz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2018
A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in SpainJesús García-Mata, Cecilio Álamo, Javier de Castro, et al.
Cell & Bioscience|August 14, 2019
miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patientsCarlos Rodríguez-Antolín, Laura Felguera-Selas, Olga Pernía, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|April 15, 2023
[New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Dolores Isla, María D Lozano, Luis Paz-Ares, et al.
Expert Review of Anticancer Therapy|September 25, 2014
Simulation and comparison of progression-free survival among patients with non-squamous non-small-cell lung cancer receiving sequential therapyStefan Walzer, Christos Chouaid, Johanna Lister, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 26, 2022
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyDolores Isla, Maria D Lozano, Luis Paz-Ares, et al.
Journal of Medical Economics|March 8, 2023
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Javier De Castro, et al.
Pageof 18